19046550

Source:http://linkedlifedata.com/resource/pubmed/id/19046550

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007222, umls-concept:C0007226, umls-concept:C0030705, umls-concept:C0074554, umls-concept:C0286651, umls-concept:C0441471, umls-concept:C1521828, umls-concept:C1548602, umls-concept:C1707455
pubmed:issue	12
pubmed:dateCreated	2008-12-2
pubmed:abstractText	To compare cardiovascular (CV) event rates and risk in patients without previous CV disease in whom atorvastatin or simvastatin was newly initiated in a managed care setting.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/19046550, http://linkedlifedata.com/resource/pubmed/commentcorrection/19046550-19046549
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/0405543
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Simvastatin, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin
pubmed:status	MEDLINE
pubmed:month	Dec
pubmed:issn	1942-5546
pubmed:author	pubmed-author:CzirakyMarkM, pubmed-author:GrochulskiDanielD, pubmed-author:HoyTraceyT, pubmed-author:JacobsonTerry ATA, pubmed-author:KuznikAndreasA, pubmed-author:WertzDebra ADA
pubmed:issnType	Electronic
pubmed:volume	83
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	1316-25
pubmed:dateRevised	2010-11-18
pubmed:meshHeading	pubmed-meshheading:19046550-Adolescent, pubmed-meshheading:19046550-Adult, pubmed-meshheading:19046550-Cardiovascular Diseases, pubmed-meshheading:19046550-Cholesterol, pubmed-meshheading:19046550-Diabetes Mellitus, pubmed-meshheading:19046550-Female, pubmed-meshheading:19046550-Follow-Up Studies, pubmed-meshheading:19046550-Heptanoic Acids, pubmed-meshheading:19046550-Humans, pubmed-meshheading:19046550-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:19046550-Kaplan-Meier Estimate, pubmed-meshheading:19046550-Male, pubmed-meshheading:19046550-Middle Aged, pubmed-meshheading:19046550-Multivariate Analysis, pubmed-meshheading:19046550-Primary Prevention, pubmed-meshheading:19046550-Proportional Hazards Models, pubmed-meshheading:19046550-Pyrroles, pubmed-meshheading:19046550-Retrospective Studies, pubmed-meshheading:19046550-Risk, pubmed-meshheading:19046550-Simvastatin, pubmed-meshheading:19046550-United States
pubmed:year	2008
pubmed:articleTitle	Comparison of cardiovascular event rates in patients without cardiovascular disease in whom atorvastatin or simvastatin was newly initiated.
pubmed:affiliation	Office of Health Promotion and Disease Prevention, Emory University, Atlanta, GA 30303, USA. tjaco02@emory.edu
pubmed:publicationType	Journal Article, Comparative Study, Research Support, Non-U.S. Gov't